Shares of GENinCode Plc (LON:GENI – Get Free Report) reached a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 3.20 ($0.04) and last traded at GBX 3.40 ($0.04), with a volume of 59570 shares changing hands. The stock had previously closed at GBX 3.60 ($0.04).
GENinCode Price Performance
The company’s 50-day simple moving average is GBX 3.97 and its 200 day simple moving average is GBX 5.38. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.27. The stock has a market capitalization of £6.02 million, a price-to-earnings ratio of -68.00 and a beta of 0.66.
GENinCode Company Profile
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Read More
- Five stocks we like better than GENinCode
- What Are Trending Stocks? Trending Stocks Explained
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Industrial Products Stocks Investing
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- The 3 Best Blue-Chip Stocks to Buy Now
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
